[1] |
SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
doi: 10.3322/caac.v71.1
|
[2] |
吴春晓, 顾凯, 龚杨明, 等. 2015年中国结直肠癌发病和死亡情况分析[J]. 中国癌症杂志, 2020, 30(4): 241-245.
|
|
WU C X, GU K, GONG Y M, et al. Analysis of incidence and mortality of colorectal cancer in China, 2015[J]. China Oncol, 2020, 30(4): 241-245.
|
[3] |
姚宏伟, 吴鸿伟, 刘荫华. 美国癌症联合委员会第8版结直肠癌分期更新及其“预后和预测”评价体系[J]. 中华胃肠外科杂志, 2017, 20(1): 24-27.
|
|
YAO H W, WU H W, LIU Y H. Improvement of prognostic and predictive network of colorectal cancer based upon the 8th edition of AJCC colorectal cancer staging system[J]. Chin J Gastrointest Surg, 2017, 20(1): 24-27.
|
[4] |
吴敏, 龙静, 杨瑶. 血清肿瘤标志物联合检验应用于结直肠癌临床诊断的价值分析[J]. 国际检验医学杂志, 2017, 38(17): 2484-2486.
|
|
WU M, LONG J, YANG Y. Value of combined test of serum tumor markers in clinical diagnosis of colorectal cancer[J]. Int J Lab Med, 2017, 38(17): 2484-2486.
|
[5] |
李勇, 姜世平, 高霞. Ki-67和CK20及CEA的表达与结直肠癌临床病理特征的关系及意义[J]. 中国现代普通外科进展, 2017, 20(5): 394-396.
|
|
LI Y, JIANG S P, GAO X. Relationship and significance between the expression of Ki-67, CK20 and CEA and clinicopathological features of colorectal cancer[J]. Chin J Curr Adv Gen Surg, 2017, 20(5): 394-396.
|
[6] |
RUBENSTEIN J H, ENNS R, HEIDELBAUGH J, et al. American gastroenterological association institute guideline on the diagnosis and management of lynch syndrome[J]. Gastroenterology, 2015, 149(3): 777-782; quize16-7.
|
[7] |
BENSON A B, VENOOK A P, AL-HAWARY M M, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021. 19(3): 329-359.
doi: 10.6004/jnccn.2021.0012
|
[8] |
中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版)[J]. 中华外科杂志, 2020, 58(8): 561-585.
|
|
National Health Commission of the People's Republic of China. Chinese protocol of diagnosis and treatment of colorectal cancer (2020 edition)[J]. Chin J Surg, 2020, 58(8): 561-585.
|
[9] |
韩安家, 黄艳, 来茂德. 肿瘤病理诊断规范(结直肠癌)[J]. 中华病理学杂志, 2016, 45(12): 822-824.
|
|
HAN A J, HUANG Y, LAI M D. Diagnostic criteria of tumor pathology (colorectal cancer)[J]. Chin J Pathol, 2016, 45(12): 822-824.
|
[10] |
于显博, 王海江, 孙振强, 等. 散发性结直肠癌患者错配修复基因蛋白表达水平及其临床意义[J]. 中国全科医学, 2014, 17(8): 883-887.
|
|
YU X B, WANG H J, SUN Z Q, et al. Mismatch repair gene protein expression and clinical significance in patients with sporadic colorectal carcinoma[J]. Chin Gen Pract, 2014, 17(8): 883-887.
|
[11] |
JUNG S B, LEE H I, OH H K, et al. Clinico-pathologic parameters for prediction of microsatellite instability in colorectal cancer[J]. Cancer Res Treat, 2012, 44(3): 179-186.
doi: 10.4143/crt.2012.44.3.179
|
[12] |
KIM C G, AHN J B, JUNG M, et al. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers[J]. Br J Cancer, 2016, 115(1): 25-33.
doi: 10.1038/bjc.2016.161
|
[13] |
NICOLINI A, FERRARI P, DUFFY M J, et al. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival[J]. Arch Surg, 2010, 145(12): 1177-1183.
doi: 10.1001/archsurg.2010.251
|
[14] |
陈舒颖, 邱芳华, 李秋明, 等. 血清DCD、CA199、CA724和CEA联合检测对大肠癌的诊断价值[J]. 实用医学杂志, 2017, 33(15): 2482-2485.
|
|
CHEN S Y, QIU F H, LI Q M, et al. Value of combined detection of serum DCD, CA199, CA724, and CEA in diagnosis of colorectal cancer[J]. J Pract Med, 2017, 33(15): 2482-2485.
|
[15] |
陈蕾, 姜北海, 邸佳柏, 等. 术前检测癌胚抗原和糖链抗原199对结直肠癌Ⅱ~Ⅲ期患者预后的判断价值[J]. 中华胃肠外科杂志, 2015(9): 914-919.
|
|
JIANG B H, DI J B, ZHANG C H, et al. Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage Ⅱ-Ⅲ colorectal cancer[J]. Chin J Gastrointest Surg, 2015(9): 914-919.
|
[16] |
邹超世, 林英, 刘康海, 等. 多种肿瘤标志物联合检测诊断结直肠癌的临床价值及预后监测研究[J]. 国际检验医学杂志, 2018, 39(23): 2960-2963.
|
|
ZOU C S, LIN Y, LIU K H, et al. Clinical value and prognostic monitoring of combined detection of multiple tumor markers in the diagnosis of colorectal cancer[J]. Int J Lab Med, 2018, 39(23): 2960-2963.
|
[17] |
KOGANEMARU S, INOSHITA N, MIURA Y, et al. Prognostic value of programmed death-ligand 1 expression in patients with stage Ⅲ colorectal cancer[J]. Cancer Sci, 2017, 108(5): 853-858.
doi: 10.1111/cas.13229
|
[18] |
傅桂霞. Array-ELISA检测6项肿瘤标志物诊断结直肠癌的临床价值分析[J]. 川北医学院学报, 2017, 32(5): 781-784.
|
|
FU G X. Clinical value of Array-ELISA in detecting six tumor markers in diagnosis of colorectal cancer[J]. J North Sichuan Med Coll, 2017, 32(5): 781-784.
|
[19] |
史汉蒙, 司君利, 崔伟丽, 等. 肿瘤相关巨噬细胞计数、基质金属蛋白酶-2及Ki-67的表达与结直肠癌预后的关系[J]. 中华消化杂志, 2015(6): 405-407.
|
|
SHI H M, SI J L, CUI W L, et al. Relationship between tumor associated macrophage count, matrix metalloproteinase-2 and Ki-67 expression and prognosis of colorectal cancer[J]. Chin J Dig, 2015(6): 405-407.
|
[20] |
MELLING N, KOWITZ C M, SIMON R, et al. High Ki-67 expression is an independent good prognostic marker in colorectal cancer[J]. J Clin Pathol, 2016, 69(3): 209-214.
doi: 10.1136/jclinpath-2015-202985
|